Wikidata

(Q46755325)

English

A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity.

scientific article

In more languages

Statements

title
A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
18272912
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18272912%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q46755325&oldid=1570027404"